Data from 2020-2021, estimates for 2022 and CAGR projections to 2027

DUBLIN, August 26, 2022 /PRNewswire/ — The report “Human Reproductive Technologies: Products and Global Markets” has been added to from offer.


To increase investment and progress in each of the three main areas of infertility, contraception and sexual dysfunction.

The report is designed to be a comprehensive business tool for taking an in-depth look at the Reproductive Drugs and Technologies markets. The geographic scope of the report is global. The report examines the reproductive health of men and women, introduces standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores the market size, identifies market players, and studies pipeline products and technologies.

Many factors influence the human reproductive arena. Countries differ in their approaches and acceptance of fertility, contraception and sexual dysfunction. Culture, religion and social environment all play a role; Depending on the country and the position of women in society, this can make a huge difference to how reproduction is treated.

The choice of contraception varies from country to country: Japan, condoms and abortions are preferred over other methods; in India, sterilization is the preferred method of birth control; in China, the use of the coil is preferred; while in Africa, injectable contraception dominates. This difference in preference between countries is also observed in the areas of fertility and sexual dysfunction.

One of the most widely publicized, celebrated and, at the time, controversial medical landmarks in this field is the use of assisted reproductive technology (ART) to manage infertility. Recent developments in the field of ART have intensified the hopes and wishes of infertile people to resolve their infertility, leading to an increasing demand for such services in both developed and developing countries.

As developments in assisted reproduction have evolved rapidly, so have the ethical, social and political controversies that surround almost every aspect of assisted reproduction. Few other fields of medicine have posed so many social and ethical questions and attracted so much public attention. Cultural differences influence the acceptance of ART.

Moreover, economic forces play a role in this market as it is an expensive business which is not affordable to many. In Asia, the doors seem to be opening for growth, but there are hurdles to overcome, such as educating doctors and patients about procedures and the social and cultural mores that influence ART.

New developments in the field of contraception have intensified the search for simpler, safer and more convenient methods of contraception. There is no miracle drug or birth control method, but scientists are pursuing several avenues of discovery to create better options for people.

Sexual dysfunction is now a disorder recognized by the general public and the medical community. Before the advent of Viagra, the disorder was present but unrecognized and largely untreated. The introduction of Viagra opened Pandora’s box in the development of sexual dysfunction drugs and devices for both sexes, at a time when female sexual dysfunction was virtually unheard of.

This area of ​​reproductive health is rife with research and discovery opportunities and will likely continue to advance over the next few years, but progress has been slow and some ED products are open to generic development.

Descriptive company profiles of major global players including Actavis, Inc., Bayer AG, EMD Serono, Inc. and Quidel Corp.

The report includes

  • Global market trend analyses, with data from 2020-2021, estimates to 2022, and compound annual growth rate (CAGR) projections to 2027

  • Assessing and forecasting overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region

  • In-depth information (facts & figures) regarding market drivers, market disincentives, and other demographic and economic factors influencing the progress of this Reproductive Health Market

  • Discussion of emerging technological trends, market opportunities and gaps by estimating current and future demand for reproductive drugs and technologies, and implications of COVID-19 on the market

  • Identification of promising new products and technologies still in the development and pipeline stage, and assessment of the likelihood of them being successfully commercialized within the next five years

  • Review of the company’s competitive landscape for the Global Human Reproductive Drugs Market, their product portfolios, global rankings, and company value share analysis based on segmental revenue

  • Major M&A deals, new product launches and other strategic industry alliances

  • Relevant patent analysis

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Industry Overview

  • Structure and function of the reproductive system

  • Man

  • Female

  • Neuroendocrine regulation

  • menarche

  • Menstrual cycle

  • Phases of Sexual Responses

  • Male sexual response

  • Female sexual response

  • Neurohormonal control of the female and male reproductive system

  • Effects of aging

  • Reproductive Health Issues and Trends

  • Contraceptive insurance

  • Over-the-counter birth control pills

  • Preimplantation genetic diagnosis

  • Novice designers

  • New use of contraceptives

  • Aging and infertility

  • Death by contraceptive patch

  • Sexual dysfunction and cancer

  • Infertility and cancer

  • Signaling pathway for fertility treatment

  • Marketing tactics

  • Male contraception

  • Merchandising targeting women

  • Counterfeit products

  • Excess embryos and fetuses

  • Stem Cells and Other Controversial Issues – Selected International Viewpoints

  • Controversial disposal of embryos

  • Demography

Chapter 4 Infertility Market

Chapter 5 Impact of Covid-19

  • Introduction

  • Covid-19: impact on the medical device and pharmaceutical industries

  • Refusal/delay in optional procedures

  • Impact of Covid-19 on the supply chain

  • Supply chain in the United States: impact of Covid-19

  • European supply chain: impact of Covid-19

  • Apac supply chain: impact of Covid-19

  • China: Impact of Covid-19

  • Impact of Covid-19 on Medical Devices and Pharmaceuticals Segments

  • Impact of Covid-19 on critical devices

  • Impact of Covid-19 on Human Reproductive Technologies and Products Markets

Chapter 6 Processing Methods

  • Fertility Pharmaceuticals

  • Presentation and types

  • Revenues and market forecasts

  • Future Advances in Infertility Products

  • Competitive analysis

Chapter 7 Assisted Reproductive Technologies

  • Introduction

  • Types

  • ivf

  • Induction of ovulation

  • Egg retrieval

  • Intracytoplasmic sperm injection (Icsi)

  • Fertilization

  • Embryo transfer

  • IVF results

  • Present

  • Zift

  • Uterus for rent

  • Egg donation

  • Frozen embryos

  • Fertility clinics in the United States

  • Revenues and market forecasts

  • Future Trends in Assisted Reproductive Technologies

  • Competitive Analysis Chapter 8 Fertility Diagnostics

  • Introduction

  • Types

  • Urine studies

  • Revenues and market forecasts

  • Competitive analysis

  • Future Advances in Diagnostic Fertility Treatment

  • Total Infertility Market Revenue and Forecast

Chapter 9 Contraception Market

  • Introduction and Overview of Contraception

  • Medications

  • Types

  • Other Medication Regimens for Contraception

  • Revenues and market forecasts

  • Competitive analysis

  • Prescription devices

  • Revenues and market forecasts

  • Competitive analysis

  • Future Advances in Contraception

  • Total market revenue and forecast

Chapter 10 Sexual Dysfunction Market

  • Presentation and overview

  • Types of Sexual Dysfunction

  • Causes of Sexual Dysfunction

  • Sexual Dysfunction Demographics

  • Medications

  • Presentation and types

  • Revenues and market forecasts

  • Competitive analysis

  • Devices

  • Revenues and market forecasts

  • Future Advances in Sexual Dysfunction

  • Total market revenue and forecast

Chapter 11 Patents

Chapter 12 Total Market

  • Total Global Market for Reproductive Technologies and Products, by Region

  • North America

  • Europe

  • Asia Pacific

  • Rest of the world

  • Total market size by category

  • Industry participants by category

  • Total Market Size by Product Type

Chapter 13 Competitive Landscape

Chapter 14 Business Profiles

  • Actavis, Inc.

  • Bayer AG

  • Bristol-Myers Squibb Co.

  • Church & Dwight Company Inc.

  • Coopersurgical Inc.

  • Eli Lilly & Co.

  • Emd Serono, Inc.

  • Ferring Pharmaceuticals

  • GlaxoSmithKline plc

  • Janssen Pharmaceutical

  • Merck Inc.

  • Novartis International AG

  • Pfizer Inc.

  • Princeton Biomeditech Corp.

  • Quidel Corp.

  • Teva Pharmaceuticals.

  • Vivu Inc.

For more information about this report visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716




View original content: – Projections-2022-and-cagr-until-2027-301613040.html

SOURCE Research and Markets

Source link

Comments are closed.